ST-5589

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameST-5589
Drug Alias NameST-5589 hydrochlorideadarotene ester derivative back-up compounds (cancer), Sigma-TauST-5589CL1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau Spa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A